Tenofovir for the prophylaxis of HBV reactivation in anti-HBC-positive patients with hematologic malignancies treated with rituximab: Preliminary results of a randomized study (preblin study)
Identifiers
Identifiers
Services
Services
Date issued
2014Journal title
JOURNAL OF HEPATOLOGY
Type of content
Publicación de congreso
